Two cheers for the CMA's new guidelines on drug company-MD relations
Gespeichert in:
Veröffentlicht in: | Canadian Medical Association journal (CMAJ) 1991-12, Vol.145 (11), p.1497-1498 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1498 |
---|---|
container_issue | 11 |
container_start_page | 1497 |
container_title | Canadian Medical Association journal (CMAJ) |
container_volume | 145 |
creator | Rapp, Morton S |
description | |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1336045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>458428131</sourcerecordid><originalsourceid>FETCH-LOGICAL-p150t-beb1f06ea103a0d2398ceed8eeb0029385a68521099059cc81a9d39d022624053</originalsourceid><addsrcrecordid>eNpVzsFLwzAYBfAgipvT_yF48VT4krRZchHGplPY8DLPIW2-bh1dUpPWsf_eibv4Lu_w4Me7ImOWK5VxwfU1GYPikAmdyxG5S2kP5wg-vSUjxmSuBYgxWWyOgVY7xJhoHSLtd0jn69lToh6PdDs0DtvGY6LBUxeHLa3CobP-lK0XNGJr-yb4dE9uatsmfLj0hHy-vmzmb9nqY_k-n62yjhXQZyWWrAaJloGw4LjQqkJ0CrEE4FqowkpVcAZaQ6GrSjGrndAOOJc8h0JMyPOf2w3lAV2Fvo-2NV1sDjaeTLCN-b_4Zme24dswISTkv8DjBYjha8DUm30Yoj9_Nhzy6VRKLsUPXbFetw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>204776626</pqid></control><display><type>article</type><title>Two cheers for the CMA's new guidelines on drug company-MD relations</title><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Rapp, Morton S</creator><creatorcontrib>Rapp, Morton S</creatorcontrib><identifier>ISSN: 0820-3946</identifier><identifier>EISSN: 1488-2329</identifier><identifier>PMID: 11649303</identifier><identifier>CODEN: CMAJAX</identifier><language>eng</language><publisher>Ottawa: CMA Impact, Inc</publisher><subject>Associations ; Pharmaceutical industry ; Physician relations ; Physicians ; Viewpoint</subject><ispartof>Canadian Medical Association journal (CMAJ), 1991-12, Vol.145 (11), p.1497-1498</ispartof><rights>Copyright Canadian Medical Association Dec 1, 1991</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1336045/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1336045/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53790,53792</link.rule.ids></links><search><creatorcontrib>Rapp, Morton S</creatorcontrib><title>Two cheers for the CMA's new guidelines on drug company-MD relations</title><title>Canadian Medical Association journal (CMAJ)</title><subject>Associations</subject><subject>Pharmaceutical industry</subject><subject>Physician relations</subject><subject>Physicians</subject><subject>Viewpoint</subject><issn>0820-3946</issn><issn>1488-2329</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNpVzsFLwzAYBfAgipvT_yF48VT4krRZchHGplPY8DLPIW2-bh1dUpPWsf_eibv4Lu_w4Me7ImOWK5VxwfU1GYPikAmdyxG5S2kP5wg-vSUjxmSuBYgxWWyOgVY7xJhoHSLtd0jn69lToh6PdDs0DtvGY6LBUxeHLa3CobP-lK0XNGJr-yb4dE9uatsmfLj0hHy-vmzmb9nqY_k-n62yjhXQZyWWrAaJloGw4LjQqkJ0CrEE4FqowkpVcAZaQ6GrSjGrndAOOJc8h0JMyPOf2w3lAV2Fvo-2NV1sDjaeTLCN-b_4Zme24dswISTkv8DjBYjha8DUm30Yoj9_Nhzy6VRKLsUPXbFetw</recordid><startdate>19911201</startdate><enddate>19911201</enddate><creator>Rapp, Morton S</creator><general>CMA Impact, Inc</general><scope>4T-</scope><scope>4U-</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>5PM</scope></search><sort><creationdate>19911201</creationdate><title>Two cheers for the CMA's new guidelines on drug company-MD relations</title><author>Rapp, Morton S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p150t-beb1f06ea103a0d2398ceed8eeb0029385a68521099059cc81a9d39d022624053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Associations</topic><topic>Pharmaceutical industry</topic><topic>Physician relations</topic><topic>Physicians</topic><topic>Viewpoint</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rapp, Morton S</creatorcontrib><collection>Docstoc</collection><collection>University Readers</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Canadian Medical Association journal (CMAJ)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rapp, Morton S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Two cheers for the CMA's new guidelines on drug company-MD relations</atitle><jtitle>Canadian Medical Association journal (CMAJ)</jtitle><date>1991-12-01</date><risdate>1991</risdate><volume>145</volume><issue>11</issue><spage>1497</spage><epage>1498</epage><pages>1497-1498</pages><issn>0820-3946</issn><eissn>1488-2329</eissn><coden>CMAJAX</coden><cop>Ottawa</cop><pub>CMA Impact, Inc</pub><pmid>11649303</pmid><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0820-3946 |
ispartof | Canadian Medical Association journal (CMAJ), 1991-12, Vol.145 (11), p.1497-1498 |
issn | 0820-3946 1488-2329 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1336045 |
source | PubMed Central; Alma/SFX Local Collection |
subjects | Associations Pharmaceutical industry Physician relations Physicians Viewpoint |
title | Two cheers for the CMA's new guidelines on drug company-MD relations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A26%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Two%20cheers%20for%20the%20CMA's%20new%20guidelines%20on%20drug%20company-MD%20relations&rft.jtitle=Canadian%20Medical%20Association%20journal%20(CMAJ)&rft.au=Rapp,%20Morton%20S&rft.date=1991-12-01&rft.volume=145&rft.issue=11&rft.spage=1497&rft.epage=1498&rft.pages=1497-1498&rft.issn=0820-3946&rft.eissn=1488-2329&rft.coden=CMAJAX&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E458428131%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=204776626&rft_id=info:pmid/11649303&rfr_iscdi=true |